Gemcitabine, Bendamustine, and Nivolumab in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma
Emory University
Emory University
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Ohio State University Comprehensive Cancer Center
National Cancer Institute (NCI)
Acrotech Biopharma Inc.
M.D. Anderson Cancer Center
Merck Sharp & Dohme LLC
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Stanford University
University of Rochester
National Cancer Institute (NCI)